A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...

Semaglutide, the active ingredient in Ozempic and Wegovy, could revolutionize the treatment of alcohol and tobacco-related ...

From "I'll never drink again" to "I'm fine to drive," psychologists reveal why we lie to ourselves after drinking alcohol and ...

Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or that teen drug use is just a rite of passage.

Jan. 23, 2025 — The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and anti-anxiety medications in adolescents and young adults has ... Changes in Opioid Use Outcomes ...

Lisa Schiff became the country’s leading art consultant, and drew her clients close. Then she stole millions from them. Now facing up to 20 years in prison, is she ready to repent? By Sarah ...